{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.1444.3.138",
  "meta" : {
    "versionId" : "6",
    "lastUpdated" : "2021-03-06T01:00:16.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "American Society of Clinical Oncology Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2023-06-23"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2021-03-06"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.138",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.1444.3.138"
    }
  ],
  "version" : "20210306",
  "name" : "GranisetronTransdermal",
  "title" : "Granisetron Transdermal",
  "status" : "active",
  "experimental" : false,
  "date" : "2021-03-06T01:00:16-05:00",
  "publisher" : "American Society of Clinical Oncology Steward",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts of medication Granisetron.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication Granisetron; generic; prescribable; transdermal.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept" : [
          {
            "code" : "825003",
            "display" : "168 HR granisetron 0.129 MG/HR Transdermal System"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:ea7927ef-e1a9-45f2-a192-5f071fb1c2cd",
    "timestamp" : "2023-11-26T19:54:22-05:00",
    "total" : 1,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "825003",
        "display" : "168 HR granisetron 0.129 MG/HR Transdermal System"
      }
    ]
  }
}
